| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 7,103874 | 07/10/2026 | 21,32% | 36,43% | *** |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 8,250000 | 07/10/2026 | 21,15% | 36,59% | *** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 159,631402 | 07/10/2026 | 20,94% | 46,46% | *** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 77,632638 | 07/10/2026 | 20,85% | 29,69% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 6,898094 | 07/10/2026 | 20,79% | 34,19% | *** |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 6,844413 | 07/10/2026 | 20,57% | 33,64% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 157,244964 | 07/10/2026 | 20,49% | 44,89% | *** |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 7,930000 | 07/10/2026 | 20,33% | 33,50% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 2.886,937461 | 07/10/2026 | 17,66% | 69,78% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 7.872,532880 | 07/10/2026 | 17,48% | 69,12% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | RVI BIOTECNOLOGÍA | 378,187349 | 07/10/2026 | 17,33% | 71,88% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | RVI BIOTECNOLOGÍA | 3.349,630000 | 07/10/2026 | 17,27% | 68,90% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 496,690000 | 07/10/2026 | 17,09% | 71,66% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 1.165,974770 | 07/10/2026 | 16,54% | 67,36% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP EUR | RVI BIOTECNOLOGÍA | 329,270000 | 07/10/2026 | 16,27% | 66,92% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | RVI BIOTECNOLOGÍA | 823,485730 | 07/10/2026 | 16,22% | 65,54% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C DIS USD | RVI BIOTECNOLOGÍA | 1.052,608034 | 07/10/2026 | 15,93% | 64,45% | *** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 116,780000 | 07/10/2026 | 15,86% | 36,95% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 123,300000 | 07/10/2026 | 15,84% | 36,80% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 82,070000 | 07/10/2026 | 15,77% | 36,56% | ** |
